ArticleFrontiers in pharmacology2024

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system.

Lisha Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.